- call +1-201-465-4211
- email sales@mrinsights.biz
A biomarker, or biological marker, generally refers to a measurable indicator of some biological state or condition. The term is also occasionally used to refer to a substance whose detection indicates the presence of a living organism.
Biomarkers are often measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.Biomarkers are used in many scientific fields.
Scope of the Report:
This report studies the Biomarker market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biomarker market by product type and applications/end industries.
The global Biomarker market is valued at 29500 million USD in 2017 and is expected to reach 29500 million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biomarker.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
QIAGEN N.V. (Netherlands)
PerkinElmer, Inc. (U.S.)
Merck Millipore (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Enzo Biochem, Inc. (U.S.)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Consumables
Service
Market Segment by Applications, can be divided into
Diagnostics Development
Drug Discovery and Development
Disease-Risk
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biomarker Market Overview
1.1 Product Overview and Scope of Biomarker
1.2 Classification of Biomarker by Types
1.2.1 Global Biomarker Revenue Comparison by Types (2017-2023)
1.2.2 Global Biomarker Revenue Market Share by Types in 2017
1.2.3 Consumables
1.2.4 Service
1.3 Global Biomarker Market by Application
1.3.1 Global Biomarker Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostics Development
1.3.3 Drug Discovery and Development
1.3.4 Disease-Risk
1.4 Global Biomarker Market by Regions
1.4.1 Global Biomarker Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biomarker Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biomarker Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biomarker Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biomarker Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biomarker Status and Prospect (2013-2023)
1.5 Global Market Size of Biomarker (2013-2023)
2 Manufacturers Profiles
2.1 QIAGEN N.V. (Netherlands)
2.1.1 Business Overview
2.1.2 Biomarker Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 QIAGEN N.V. (Netherlands) Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.2 PerkinElmer, Inc. (U.S.)
2.2.1 Business Overview
2.2.2 Biomarker Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 PerkinElmer, Inc. (U.S.) Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck Millipore (U.S.)
2.3.1 Business Overview
2.3.2 Biomarker Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Millipore (U.S.) Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bio-Rad Laboratories, Inc. (U.S.)
2.4.1 Business Overview
2.4.2 Biomarker Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.5 Enzo Biochem, Inc. (U.S.)
2.5.1 Business Overview
2.5.2 Biomarker Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Enzo Biochem, Inc. (U.S.) Biomarker Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biomarker Market Competition, by Players
3.1 Global Biomarker Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biomarker Players Market Share
3.2.2 Top 10 Biomarker Players Market Share
3.3 Market Competition Trend
4 Global Biomarker Market Size by Regions
4.1 Global Biomarker Revenue and Market Share by Regions
4.2 North America Biomarker Revenue and Growth Rate (2013-2018)
4.3 Europe Biomarker Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biomarker Revenue and Growth Rate (2013-2018)
4.5 South America Biomarker Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biomarker Revenue and Growth Rate (2013-2018)
5 North America Biomarker Revenue by Countries
5.1 North America Biomarker Revenue by Countries (2013-2018)
5.2 USA Biomarker Revenue and Growth Rate (2013-2018)
5.3 Canada Biomarker Revenue and Growth Rate (2013-2018)
5.4 Mexico Biomarker Revenue and Growth Rate (2013-2018)
6 Europe Biomarker Revenue by Countries
6.1 Europe Biomarker Revenue by Countries (2013-2018)
6.2 Germany Biomarker Revenue and Growth Rate (2013-2018)
6.3 UK Biomarker Revenue and Growth Rate (2013-2018)
6.4 France Biomarker Revenue and Growth Rate (2013-2018)
6.5 Russia Biomarker Revenue and Growth Rate (2013-2018)
6.6 Italy Biomarker Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biomarker Revenue by Countries
7.1 Asia-Pacific Biomarker Revenue by Countries (2013-2018)
7.2 China Biomarker Revenue and Growth Rate (2013-2018)
7.3 Japan Biomarker Revenue and Growth Rate (2013-2018)
7.4 Korea Biomarker Revenue and Growth Rate (2013-2018)
7.5 India Biomarker Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biomarker Revenue and Growth Rate (2013-2018)
8 South America Biomarker Revenue by Countries
8.1 South America Biomarker Revenue by Countries (2013-2018)
8.2 Brazil Biomarker Revenue and Growth Rate (2013-2018)
8.3 Argentina Biomarker Revenue and Growth Rate (2013-2018)
8.4 Colombia Biomarker Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biomarker by Countries
9.1 Middle East and Africa Biomarker Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biomarker Revenue and Growth Rate (2013-2018)
9.3 UAE Biomarker Revenue and Growth Rate (2013-2018)
9.4 Egypt Biomarker Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biomarker Revenue and Growth Rate (2013-2018)
9.6 South Africa Biomarker Revenue and Growth Rate (2013-2018)
10 Global Biomarker Market Segment by Type
10.1 Global Biomarker Revenue and Market Share by Type (2013-2018)
10.2 Global Biomarker Market Forecast by Type (2018-2023)
10.3 Consumables Revenue Growth Rate (2013-2023)
10.4 Service Revenue Growth Rate (2013-2023)
11 Global Biomarker Market Segment by Application
11.1 Global Biomarker Revenue Market Share by Application (2013-2018)
11.2 Biomarker Market Forecast by Application (2018-2023)
11.3 Diagnostics Development Revenue Growth (2013-2018)
11.4 Drug Discovery and Development Revenue Growth (2013-2018)
11.5 Disease-Risk Revenue Growth (2013-2018)
12 Global Biomarker Market Size Forecast (2018-2023)
12.1 Global Biomarker Market Size Forecast (2018-2023)
12.2 Global Biomarker Market Forecast by Regions (2018-2023)
12.3 North America Biomarker Revenue Market Forecast (2018-2023)
12.4 Europe Biomarker Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biomarker Revenue Market Forecast (2018-2023)
12.6 South America Biomarker Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biomarker Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biomarker Picture
Table Product Specifications of Biomarker
Table Global Biomarker and Revenue (Million USD) Market Split by Product Type
Figure Global
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
